Global Stem Cells Group announces the launch of two new stem cell treatment clinics in the cities of Arica and Iquique in northern Chile. The facilities are part of the international biotech company’s expanding presence in Latin America. MIAMI, May 31, 2016—Global Stem Cells Group, a leading international biotechnology company, announces the launch of operations

stem cells, stem cell research, Santiago symposium

Molecular biologist, immunologist and researcher Duncan Ross, Ph.D., founder of Kimera Labs, has joined the Global Stem Cells Group Advisory Board faculty. Global Stem Cells Group CEO Benito Novas announced that Duncan Ross, Ph.D. has joined the GSCG Advisory Board. Ross is the founder of GSCG affiliate Kimera Labs in Miami. In 2004, Ross received

stem cells, stem cell symposium, Santiago biotech lab

Global Stem Cells Group and the University of Santiago, Chile have endorsed an Asian-Pacific alliance for a regenerative medicine and stem cell symposium July 1-2 at the university’s Santiago campus and other stem cell protocol management initiatives. Through the alliance, the two organizations established a working agenda for collaborative initiatives in stem cell and regenerative

stem cells, stem cell research, Santiago Chile symposium

Global Stem Cells Group Advisory Board member Duncan Ross, Ph.D., founder of Kimera Research Labs, will be the keynote speaker at the Global Stem Cells Group Symposium in Santiago, Chile July 1-2, 2016. MIAMI, April 26, 2016–Global Stem Cells Group has announced that affiliate Kimera Research Labs founder Duncan Ross, Ph.D., a GSCG Advisory Board

Global Stem Cells Group and Kimera Research Labs have announced an alliance to conduct scientific research on highly manipulated cells and culture expansion, and cryopreservation of autologous stem cells. MIAMI, April 26, 2016–Global Stem Cells Group and Kimera Research Labs have announced an alliance to conduct scientific research on highly manipulated stem cells and culture

Global Stem Cells Group has announced plans to hold clinical trials, pending IRB approval, for bone marrow stem cell treatments targeting knee osteoarthritis. The trials will be held in five GSCG facilities in the U.S. and South America, with 25 patients accepted for each location. MIAMI, March 31, 2016—Pending Institutional Review Board (IRB) approval, Global

Global Stem Cells Group has begun the manufacturing phase of Progenikine™, a new SVF closed system kit utilizing EmCyte technology, containing all the elements necessary to process adipose tissue and obtain stromal vascular fraction in a sterile environment. MIAMI, March 31, 2016—Global Stem Cells Group, Inc. has announced that Progenikine™, its new and approved SVF

Global Stem Cells Group has announced plans to inaugurate its new stem cell center in Quito, Ecuador with an inaugural conference and stem cell training event Feb. 24-March 6. The new facility will offer the latest stem cell therapies to treat a variety of patient needs. MIAMI, Feb. 22, 2016—Global Stem Cells Group, has announced

Global Stem Cells Group has announced the opening of a new stem cell clinic in Quito, Ecuador. The new facility will offer the latest stem cell and regenerative medicine treatments for orthopedic and trauma applications. MIAMI, Feb. 11, 2016—Global Stem Cells Group, has announced the opening of its new stem cell treatment clinic in Quito,

Global Stem Cells Group, a world leader in regenerative medicine, has announced a new agreement with Bankok,Thailand-based Global Stem Cells Network (GSCN) to distribute exosome injection and other biological products to stem cell researchers and phsyicians in 15 Latin American countries, including Mexico, Costa Rica, Dominican Republic, Colombia, Argentina, Nicaragua, Panama, El Salvador, Venezuela, Peru,

TOP